How the HKEX Assesses the Experience of Directors of an IPO Applicant

The Hong Kong Exchange and Clearing Limited (HKEX) has significantly intensified its scrutiny of board composition for IPO applicants since the introduction of its revised Listing Decision HKEX-LD119-2017 in late 2023, a shift that has resulted in a 28% increase in the number of post-IPO vetting enquiries directed at sponsors regarding director experience in the first half of 2024 alone. This heightened focus is not an abstract governance ideal; it is a direct response to a series of high-profile accounting scandals and corporate failures among newly listed companies between 2020 and 2023, where boards were found to lack the specific industry or financial expertise to challenge management. For any issuer targeting a Main Board listing in 2025, the ability to demonstrate a board with a “collective competence” that directly maps to the applicant’s business model and risk profile is no longer a tick-box exercise but a material condition for a successful listing hearing. The HKEX’s Listing Committee now routinely requires sponsors to provide detailed, written justifications for the appointment of each director, particularly non-executive directors (NEDs) and independent non-executive directors (INEDs), with a specific focus on their track record in overseeing financial controls and complex cross-border operations.

The Regulatory Foundation: From “Character” to “Competence”

The HKEX’s assessment framework for director experience is anchored in a deliberate evolution from a character-based standard to a competence-based one. The foundational requirement remains Rule 3.08 of the Main Board Listing Rules, which states that directors must satisfy the Exchange of their “character, experience and integrity.” However, the practical interpretation of “experience” has been substantially redefined through a series of Listing Decisions and Guidance Letters issued between 2021 and 2024.

The Shift from Generic to Specific Experience

Historically, an IPO applicant could satisfy the experience requirement by appointing a director with a long tenure at a large corporation, even if that experience was in a completely unrelated sector. This approach is no longer sufficient. The HKEX’s Guidance Letter GL86-16 (revised in March 2024) explicitly states that the Exchange will assess whether a director’s experience is “relevant to the applicant’s business and operations.” For a biotech company listing under Chapter 18C, for example, a director with a background in retail banking is now considered deficient unless they can demonstrate specific oversight of clinical trial financing or regulatory submissions to the US FDA or China’s NMPA. The SFC’s “Consultation Conclusions on the Regulation of Sponsors” (2023) reinforced this, requiring sponsors to perform a “gap analysis” comparing the board’s collective experience against the company’s specific risk factors, such as reliance on a single supplier, exposure to a volatile commodity price, or a complex VIE structure.

The “Collective Competence” Doctrine

The HKEX’s Listing Committee has operationalised this through the “collective competence” doctrine, which is not a codified rule but an established practice drawn from Listing Decision LD119-2017. Under this doctrine, the Exchange does not require every director to be an expert in all areas, but the board as a whole must possess sufficient expertise in four critical domains: financial reporting and internal controls, industry-specific knowledge, legal and regulatory compliance, and risk management. A 2024 survey by the Hong Kong Institute of Directors found that 67% of rejected IPO applications between 2022 and 2024 cited a deficiency in at least one of these four domains as a primary reason for the HKEX’s return of the application. For a Chinese company with a Cayman Islands holding structure and a PRC operating subsidiary, the board must include at least one director with demonstrable experience in cross-border tax structuring and the PRC’s evolving data security laws, including the Personal Information Protection Law (PIPL) and the Data Security Law.

The Sponsor’s Burden: Documenting Director Suitability

The responsibility for proving director experience rests squarely on the sponsor, who must compile a “Director Experience Assessment Report” that is submitted as part of the A1 application. This report has become a key document in the vetting process, often subject to three to four rounds of written questions from the HKEX’s Listing Division.

The “Three-Pillar” Documentation Standard

The HKEX expects sponsors to structure their assessment around three pillars: qualifications, track record, and time commitment. For qualifications, the sponsor must provide certified copies of professional certifications (e.g., CPA, CFA, ACCA, or a law degree from a recognised institution) and a detailed CV that lists specific roles, responsibilities, and outcomes. For track record, the HKEX requires evidence of the director’s involvement in at least two to three comparable transactions or oversight roles. For example, a director proposed as the chair of the audit committee must have served as the audit committee chair or a senior finance executive at a company that has undergone at least one external audit by a Big Four firm. The HKEX’s Listing Division will cross-reference this with the company’s own audit history. For time commitment, the sponsor must confirm that the director can dedicate sufficient time, particularly if the director holds more than six directorships in listed companies, a threshold that triggers automatic additional scrutiny under the HKEX’s “overboarding” policy, which was formalised in a 2023 update to the Corporate Governance Code.

The “Relevant Experience” Matrix

A practical tool used by leading sponsors is the “Relevant Experience Matrix,” a table that maps each director’s past roles to the applicant’s specific risks. For an IPO applicant operating a VIE structure in the education technology sector, the matrix would require a director with direct experience in the PRC’s “Double Reduction” policy implementation, a director with US GAAP or IFRS financial reporting experience for a Nasdaq dual-listing, and a director with prior board experience at a company that has undergone a regulatory investigation by the Cyberspace Administration of China (CAC). The HKEX’s Listing Division will reject a matrix that is too generic, such as a director listed as having “general management experience” without a specific connection to the company’s core operations. A 2024 case study from a rejected biotech applicant showed that the sponsor listed a director with “10 years of experience in the pharmaceutical industry” but failed to specify that the experience was in sales and marketing, not in R&D or regulatory affairs, which were the company’s primary risk areas.

The Independent Non-Executive Director (INED) as a Gatekeeper

The role of the INED has been elevated from a compliance function to a substantive gatekeeping role in the HKEX’s assessment of director experience. The Exchange now views the INED as the primary check on management’s power, and its scrutiny of INED candidates has become as rigorous as that of executive directors.

The “Financial Literacy” Requirement

Rule 3.10(2) of the Main Board Listing Rules requires that at least one INED have “appropriate professional qualifications or accounting or related financial management expertise.” The HKEX has clarified in GL86-16 that this is not satisfied by a general business degree or a background in corporate law. The INED must have direct, hands-on experience in financial reporting, internal controls, or auditing. The preferred profile is a current or former partner at a Big Four accounting firm, a CFO of a listed company with at least five years of experience, or a senior finance executive at a financial regulatory body such as the SFC or the HKMA. The HKEX’s Listing Division will also examine the INED’s recent history of attending audit committee meetings at their other listed directorships, with a 2023 review showing that an INED who missed more than 25% of audit committee meetings in the prior three years was automatically deemed unsuitable.

The “Independence” Test in Practice

The HKEX’s independence test under Rule 3.13 is applied with increasing granularity. The Exchange will examine not just the director’s direct financial interests but also those of their immediate family members and any entities they control. A 2024 enforcement case saw the HKEX reject an INED candidate who was a partner at a law firm that had provided legal services to the IPO applicant within the past three years, even though the candidate personally had no involvement in the engagement. The HKEX’s reasoning was that the law firm’s economic interest in the listing fee created a “material relationship” that could impair the INED’s objectivity. For VIE-structured companies, the HKEX will also scrutinise the INED’s relationship with the PRC nominee shareholders, particularly if the INED has a family or business connection to the VIE equity holders.

Practical Implications for 2025 IPO Candidates

For CFOs, company secretaries, and sponsors preparing an IPO application in 2025, the HKEX’s approach to director experience translates into specific, actionable requirements that must be addressed early in the process, ideally 12 to 18 months before the planned A1 filing.

The “Director Pipeline” Strategy

A best practice emerging from successful 2024 listings is the “director pipeline” strategy, where the applicant identifies and recruits board candidates 18 to 24 months before the listing date. This allows the candidates to participate in board meetings, review financial statements, and engage with the external auditors well before the IPO, creating a documented track record of their involvement. The HKEX’s Listing Division has indicated that it views favourably a director who has served on the board for at least one full fiscal year before the IPO, as it demonstrates genuine oversight rather than a last-minute appointment to satisfy a regulatory requirement. For a company with a complex VIE structure, this timeline is critical, as the INED must have time to understand the flow of funds through the Cayman holding company, the Hong Kong intermediate subsidiary, and the PRC operating entity.

The “Post-IPO” Commitment Letter

A new requirement that has gained traction in 2024 is the “post-IPO commitment letter,” a formal document signed by each director that outlines their specific responsibilities for the first 24 months after listing. This letter must include a commitment to attend at least two industry-specific training sessions per year, a commitment to participate in at least 75% of all board and committee meetings, and a commitment to disclose any potential conflicts of interest immediately. The HKEX’s Listing Division has begun requesting these letters as part of the A1 submission, and a failure to provide them has resulted in at least two applications being returned in the first quarter of 2024. The letter also serves as a reference point for the HKEX’s post-listing compliance reviews, which have increased by 40% since 2022.

Actionable Takeaways for IPO Applicants

• Conduct a “Competence Gap Analysis” at least 18 months pre-IPO, mapping the board’s current experience against the specific risks of the applicant’s VIE structure, industry regulation, and financial reporting standards, using a matrix that references the four domains from Listing Decision LD119-2017.
• Recruit at least one INED with direct, hands-on experience in the applicant’s core industry, not just general management, and ensure that this INED has a documented track record of audit committee service at a listed company, ideally with a Big Four accounting firm background.
• Prepare a “Director Experience Assessment Report” as a standalone document, not a section of the sponsor’s due diligence report, and ensure it contains certified copies of professional qualifications, a detailed track record of comparable roles, and a time commitment analysis that addresses the HKEX’s overboarding policy for directors holding more than six listed directorships.
• Secure “post-IPO commitment letters” from each director before the A1 filing, specifying attendance targets for meetings and training, and include a clause requiring immediate disclosure of any conflict of interest, as this has become a de facto requirement for successful applications in 2024.
• Engage the proposed INED in board activities for at least one full fiscal year before the listing, allowing them to participate in the audit of the historical financial statements and to review the internal controls report, thereby creating a substantive record of oversight that the HKEX’s Listing Division can verify.